Repurposed Cancer Drug Could Treat Duchenne Muscular Dystrophy

News   Jun 30, 2017 | Original Story from the NIH

 
Repurposed Cancer Drug Could Treat Duchenne Muscular Dystrophy

Diaphragm muscle from SU9516 treated dystrophin deficient mouse showing nuclei (blue), myofibers (outlined in red) and regenerating muscle fibers (green). Credit: Burkin lab at the University of Nevada, Reno School of Medicine

 
 
 
 

RELATED ARTICLES

Tiny “Tornado” Boosts Performance of Electrospray Ionization Mass Spectrometry

News

Known as Dry Ion Localization and Locomotion (DRILL), the new device creates a swirling flow that can separate electrospray droplets depending on their size.

READ MORE

Researchers Develop New Method to Generate Human Antibodies

News

Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.

READ MORE

Large-Scale Production of Living Brain Cells Enables Entirely New Research

News

After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE